Skip to content

Clinical trials

Neuralgia, Postherpetic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia, Postherpetic Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20032
20041
20051
20066
20073
20088
20095
20105
20116
20123
20132
20141
20152
20161
20171
20191
20201
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated9
Unknown status3
Recruiting2
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
University of California, San Francisco4
Depomed3
NeurogesX3
Allergan2
Endo USA Inc., a Keenova Therapeutics Company2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Teva Branded Pharmaceutical Products R&D, Inc.2
University of Minnesota2
Winston Laboratories2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia, Postherpetic60
Herpes Zoster21
Neuralgia18
Pain13
Complex Regional Pain Syndromes6
Chronic Pain4
Diabetic Neuropathies4
Peripheral Nervous System Diseases4
Postoperative Pain4
Back Pain3

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.